510(k) · Cleared
Recalled · 2006Polygraft BGS; Bone Graft Substitute
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Osteobiologics, Inc. · MQV Filler, Bone Void, Calcium Compound
Cleared on Dec 17, 2004 as substantially equivalent to K030288 (Osteobiologics, Inc., 2003) after a 340-day review. Its family tree reaches back 3 generations to 1996. 23 later devices descend from it. It has been recalled once.
- Decided
- Dec 17, 2004
- Review
- 340 days
- Class
- Class II
- Product code
- MQV
- Recalls
- 1
- Predicates
- 1
Its longest line of descent runs back 3 generations to K960978 (1996). 4 ancestors in all. 23 later devices descend from it, 4 citing it directly.
- Root · 3 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
- 2 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
- 1 generation backK030288 Polygraft Bone Graft SubstituteOsteobiologics, Inc. · 2003
- This deviceK040047 Polygraft BGS; Bone Graft SubstituteOsteobiologics, Inc. · 2004
- Descendant · cites it directly · 13 of its ownK063359 INQUIsto Technologies, Inc. · 2007
- Descendant · 2 generations on · 11 of its ownK071428 INQUIsto Technologies, Inc. · 2007
- Descendant · 2 generations on · 9 of its ownK103799 Inqu Paste Mix PlusIsto Technologies, Inc. · 2011
- Descendant · 3 generations on · 8 of its ownK130392 Kinex BioactiveGlobus Medical, Inc. · 2013
- Descendant · cites it directly · 7 of its ownK060917 Kensey Nash Bone Void FillerKensey Nash Corporation · 2006
Showing 5 of 23 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 23 · See all- K063359INQUIsto Technologies, Inc. · 2007 · cites it directly13descendants
- K071428INQUIsto Technologies, Inc. · 2007 · 2 generations on11descendants
- K103799Inqu Paste Mix PlusIsto Technologies, Inc. · 2011 · 2 generations on9descendants
- K130392Kinex BioactiveGlobus Medical, Inc. · 2013 · 3 generations on8descendants
- K060917Kensey Nash Bone Void FillerKensey Nash Corporation · 2006 · cites it directly7descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K960978 | Wright Plaster of Paris Pellets (Subject to Revision) | Wrightmedicaltechnologyinc | 1996 | — |
| −2 | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05… | Interpore Intl. | 1998 | — |
| −1 | K030288 | Polygraft Bone Graft Substitute | Osteobiologics, Inc. | 2003 | — |
| 0 (this device) | K040047 | Polygraft BGS; Bone Graft Substitute | Osteobiologics, Inc. | 2004 | — |
| +1 | K063359 | INQU | Isto Technologies, Inc. | 2007 | — |
| +2 | K071428 | INQU | Isto Technologies, Inc. | 2007 | — |
| +2 | K103799 | Inqu Paste Mix Plus | Isto Technologies, Inc. | 2011 | — |
| +3 | K130392 | Kinex Bioactive | Globus Medical, Inc. | 2013 | — |
| +1 | K060917 | Kensey Nash Bone Void Filler | Kensey Nash Corporation | 2006 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 5 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 2 | 0 |
| 2012 | 1 | 0 |
| 2013 | 2 | 0 |
| 2014 | 1 | 0 |
| 2017 | 2 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2023 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K030288 | Polygraft Bone Graft SubstituteSummary page 1…rformance of the device. Substantial Equivalence: The PolyGraftTim BGS is substantially equivalent in design, function and performance to the PolyGrafiTM BGS cleared as K030288 on July 17, 2003. Testing: Biocompatibility assessment performed by independent certified laboratories demonstrated the biocompa… | 2003 |
What descends from it? (23)
See all 234 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Sep 29, 2006 | Not classified | Z-0440-2007 | Other | Mis-packaging-product in the package may be a different size than indicated on the labeling. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 2.3 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K063359 (Isto Technologies, Inc., 2007) has gone furthest, with 13 descendants of its own.
- 5 other devices also cite its predicate K030288.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
What is it indicated for?
The PolyGraftTM BGS is to be used to fill bony voids or gaps caused by trauma or surgery that are not intrinsic to the stability of the bony structure. The PolyGraftTM BGS is intended to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that…
Read the full statement (128 words)
The PolyGraftTM BGS is to be used to fill bony voids or gaps caused by trauma or surgery that are not intrinsic to the stability of the bony structure. The PolyGraftTM BGS is intended to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process. The PolyGraft TM BGS may be combined with autogenous blood products, such as platelet rich plasma, and/or sterile fluids, such as saline or Ringer's solution. The addition of these autogenous products does not alter the performance of the device.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K040047 · printed Nov 5, 2026
Cite this page
510(k) Report. “K040047: Polygraft BGS; Bone Graft Substitute.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K040047
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026